IFNB1 and myeloid sarcoma: IFN-β therapy reduction of relapses, progression, cognitive loss, MRI lesions, and prolonged longevity in MS [8], may be linked to stress-induced repair mechanisms [78], and enduring changes in immune and neurotrophic homeostasis.